Here's why it's time to take note of small and mid-cap pharma stocks
Deriving a higher share of revenue from the domestic market is a major positive for companies such as Ajanta Pharma and JB Chemicals & Pharmaceuticals.
Source: moneycontrol.com
Stay updated with breaking news from Pharma Sector. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Deriving a higher share of revenue from the domestic market is a major positive for companies such as Ajanta Pharma and JB Chemicals & Pharmaceuticals.
Chairman of the Pasban Democratic Party expressed concerns over increase in prices of medicines
KARACHI: The pharmaceutical industry has rejected government’s move of increasing drugs prices by 20 percent,...
Analysts believe Ipca Labs would have been better-placed had they committed this growth capital to secularly growing within the India market.
Opinion is split, but most analysts recommend waiting for more clarity from Lupin.